April 2018

Spring has finally sprung. New guidelines for Clostridium difficile infection have been published, and the April issue of Contagion® is here with a bevy of interesting content.

Antibiotic resistance continues to grow, and it’s plaguing health care providers and patients alike.

Quick action was needed against this very rare cause of fungal endocarditis.

Expert panelists in the field of infectious diseases discuss the growing threat of antimicrobial resistance.

Staff nurses are underused but potentially valuable contributors to antibiotic stewardship.

More than 2 million cases of gonorrhea, chlamydia, and syphilis were diagnosed in 2016, the highest number of those sexually transmitted infections (STIs) ever reported.

New agents are in development, but none represent a magic bullet for the problems that CRE infections present.

A review of the current literature and future directions.

Unique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.

Study results confirm both drug regimens are solid choices for many patients with HIV.

Many patients with pneumonia are empirically treated with anti-MRSA therapy, leaving antimicrobial stewardship programs faced with the challenge of identifying patients who truly warrant continuation of this therapy.

Given the impressive efficacy of fecal microbiota transplantation (FMT) on decreasing recurrence of Clostridium difficile infection (CDI), the next logical step is seeing how it works for hospitalized patients with CDI.

This breakthrough vaccine is quickly becoming an integral part of the adult immunization arsenal.